Intra-Cellular Therapies revenue was $60.61 k in FY, 2019
Intra-Cellular Therapies revenue breakdown by business segment: 33.6% from License and collaboration revenue and 66.4% from Grant Revenue
|FY, 2015||FY, 2014|
|License and collaboration revenue||$30.66 k||$547.55 k|
|Grant Revenue||$60.71 k||$29.76 k|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.